Correlation Between Khiron Life and Telo Genomics

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Khiron Life and Telo Genomics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Khiron Life and Telo Genomics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Khiron Life Sciences and Telo Genomics Corp, you can compare the effects of market volatilities on Khiron Life and Telo Genomics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Khiron Life with a short position of Telo Genomics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Khiron Life and Telo Genomics.

Diversification Opportunities for Khiron Life and Telo Genomics

0.0
  Correlation Coefficient

Pay attention - limited upside

The 3 months correlation between Khiron and Telo is 0.0. Overlapping area represents the amount of risk that can be diversified away by holding Khiron Life Sciences and Telo Genomics Corp in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Telo Genomics Corp and Khiron Life is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Khiron Life Sciences are associated (or correlated) with Telo Genomics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Telo Genomics Corp has no effect on the direction of Khiron Life i.e., Khiron Life and Telo Genomics go up and down completely randomly.

Pair Corralation between Khiron Life and Telo Genomics

Assuming the 90 days trading horizon Khiron Life is expected to generate 22.72 times less return on investment than Telo Genomics. But when comparing it to its historical volatility, Khiron Life Sciences is 4.07 times less risky than Telo Genomics. It trades about 0.01 of its potential returns per unit of risk. Telo Genomics Corp is currently generating about 0.07 of returns per unit of risk over similar time horizon. If you would invest  20.00  in Telo Genomics Corp on September 14, 2024 and sell it today you would lose (14.20) from holding Telo Genomics Corp or give up 71.0% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionFlat 
StrengthInsignificant
Accuracy99.8%
ValuesDaily Returns

Khiron Life Sciences  vs.  Telo Genomics Corp

 Performance 
       Timeline  
Khiron Life Sciences 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Khiron Life Sciences has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of comparatively stable basic indicators, Khiron Life is not utilizing all of its potentials. The newest stock price uproar, may contribute to short-horizon losses for the private investors.
Telo Genomics Corp 

Risk-Adjusted Performance

11 of 100

 
Weak
 
Strong
Good
Compared to the overall equity markets, risk-adjusted returns on investments in Telo Genomics Corp are ranked lower than 11 (%) of all global equities and portfolios over the last 90 days. Despite nearly uncertain basic indicators, Telo Genomics reported solid returns over the last few months and may actually be approaching a breakup point.

Khiron Life and Telo Genomics Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Khiron Life and Telo Genomics

The main advantage of trading using opposite Khiron Life and Telo Genomics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Khiron Life position performs unexpectedly, Telo Genomics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Telo Genomics will offset losses from the drop in Telo Genomics' long position.
The idea behind Khiron Life Sciences and Telo Genomics Corp pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Aroon Oscillator module to analyze current equity momentum using Aroon Oscillator and other momentum ratios.

Other Complementary Tools

Pair Correlation
Compare performance and examine fundamental relationship between any two equity instruments
Fundamental Analysis
View fundamental data based on most recent published financial statements
Latest Portfolios
Quick portfolio dashboard that showcases your latest portfolios
Equity Forecasting
Use basic forecasting models to generate price predictions and determine price momentum
Top Crypto Exchanges
Search and analyze digital assets across top global cryptocurrency exchanges